Issued Patents All Time
Showing 25 most recent of 125 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421197 | Aminopyrazine derivatives as PI3K-γ inhibitors | Brent Douty, Yanran Ai, David M. Burns, Nikoo Falahatpisheh, Daniel Levy +6 more | 2025-09-23 |
| 12365668 | Aminopyrazine diol compounds as PI3K-y inhibitors | Stacey Shepard, Nikoo Falahatpisheh, Lixin Shao | 2025-07-22 |
| 12227502 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6H)-ones as inhibitors of BET proteins | Thomas P. Maduskuie, Jr., Nikoo Falahatpisheh | 2025-02-18 |
| 12201636 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Eddy W. Yue, Song Mei, Joseph Glenn +2 more | 2025-01-21 |
| 12173006 | Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor | Brent Douty, David M. Burns, Zhongjiang Jia, Daniel Levy, Eddy W. Yue | 2024-12-24 |
| 12152033 | Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders | Yun-Long Li, Eddy W. Yue, Song Mei, Brent Douty | 2024-11-26 |
| 12129262 | CDK inhibitors and their use as pharmaceuticals | Xiaowei Wu, Andrew W. Buesking, Ryan Holmes, Sarah Pawley, Katarina Rohlfing | 2024-10-29 |
| 12030885 | Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors | Andrew W. Buesking, Richard B. Sparks, Brent Douty, Nikoo Falahatpisheh, Lixin Shao +5 more | 2024-07-09 |
| 12006320 | Heterocyclic derivatives as PI3K inhibitors | Stacey Shepard, Yanran Ai, Nikoo Falahatpisheh, Lixin Shao, Artem Shvartsbart | 2024-06-11 |
| 11999751 | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors | Yun-Long Li | 2024-06-04 |
| 11952367 | Pyridine and pyridimine compounds as PI3K-gamma inhibitors | Richard B. Sparks, Stacey Shepard, Andrew W. Buesking, Lixin Shao, Haisheng Wang +1 more | 2024-04-09 |
| 11939340 | CDK inhibitors and their use as pharmaceuticals | Jincong Zhuo, Xiaowei Wu, Katarina Rohlfing | 2024-03-26 |
| 11926616 | Aminopyrazine diol compounds as PI3K-γ inhibitors | Stacey Shepard, Nikoo Falahatpisheh, Lixin Shao | 2024-03-12 |
| 11926630 | Tertiary alcohols as PI3K-γ inhibitors | Brent Douty, Andrew W. Buesking, David M. Burns, Nikoo Falahatpisheh, Ravi Kumar Jalluri +7 more | 2024-03-12 |
| 11819505 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Eddy W. Yue, Brent Douty, Song Mei | 2023-11-21 |
| 11773102 | Heterocyclic compounds as PI3K-γ inhibitors | Artem Shvartsbart, Stacey Shepard, Lixin Shao, Nikoo Falahatpisheh, Ge Zou +4 more | 2023-10-03 |
| 11702416 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | Thomas P. Maduskuie, Jr., Nikoo Falahatpisheh | 2023-07-18 |
| 11702423 | BRM targeting compounds and associated methods of use | Hong-Nien Lin, Philip Pitis, Liang Lu | 2023-07-18 |
| 11685744 | CDK inhibitors and their use as pharmaceuticals | Andrew W. Buesking, Jincong Zhuo, Ryan Holmes, Sarah Pawley, Xiaowei Wu | 2023-06-27 |
| 11673893 | CDK inhibitors and their use as pharmaceuticals | Liang Lu, Rupa Shetty, Chaofeng Dai, Raul Andrew Leal, Klare Lazor Bersch | 2023-06-13 |
| 11622970 | BCL-2 inhibitors and their use as pharmaceuticals | Jincong Zhuo, Peng Wei, Jialiang Wang | 2023-04-11 |
| 11498926 | Tricyclic heterocycles as BET protein inhibitors | Richard B. Sparks, Thomas P. Maduskuie, Jr., James D. Rodgers | 2022-11-15 |
| 11433071 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Eddy W. Yue, Song Mei, Joseph Glenn +4 more | 2022-09-06 |
| 11401280 | Pyrimidinones as PI3K inhibitors | Yun-Long Li, Brian W. Metcalf | 2022-08-02 |
| 11396502 | Substituted heterocyclic derivatives as PI3K inhibitors | Stacey Shepard | 2022-07-26 |